Xenon Pharmaceuticals Inc. (XENE) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net income	-125.4	-78.9	-28.8	-40.0	-31.6	-30.7	-23.0	-15.8
Depreciation and amortization	1.6	0.9	0.6	0.4	0.6	0.6	0.9	1.0
Stock-based compensation				2.9	2.6	2.2	2.2	3.7
Deferred taxes				-0.1	-0.1
Change in working capital [+]	38.8	24.3	9.8	14.2	0.1	0.6	1.7	-14.0
Accounts receivable				-0.7	0.3	-0.2	0.1	-0.1
Other current assets				-0.8	-0.9	0.6	0.6	-1.2
Deferred revenues							-0.2	-11.6
Other	38.8	24.3	9.8	15.7	0.8	0.2	1.2	-1.1
Other operating activities	-13.5	-15.9	-29.8	17.9	-6.3	-1.5	-1.3	6.9
Cash from operations	-98.4	-69.5	-48.1	-4.7	-34.7	-28.7	-19.6	-18.1

Capital expenditures	2.9	2.1	2.6	-1.2	-0.5	-0.3	-0.3	-0.6
Purchases of property and equipment	2.9	2.1	2.6	-1.2	-0.5	-0.3	-0.3	-0.6
Purchases of short-term investments, net	551.1	389.5	228.9	-65.0	-28.5	24.6	-47.6	10.7
Purchases of short-term investments	551.1	389.5	228.9	-140.5	-77.0	-28.0	-47.6
Sales of short-term investments				75.5	48.5	52.6		10.7
Other cash from investing	-850.0	-638.3	-248.4
Cash from investing	-296.0	-246.8	-16.8	-66.2	-29.0	24.3	-47.8	10.2

Issuance of common stock, net				27.4	102.9		23.8
Option exercises	0.7	0.3	0.1	0.1	0.3	0.2	0.1	0.3
Other cash from financing	279.2	447.8	85.9	0.2	9.0	7.2	0.3	0.6
Cash from financing	278.5	447.5	85.8	27.5	111.6	7.1	24.0	0.3

Free cash flow	-95.5	-67.5	-45.5	-6.0	-35.2	-29.0	-19.8	-18.7
Per share (diluted)	($1.58)	($1.55)	($1.32)	($0.23)	($1.81)	($1.61)	($1.28)	($1.31)

Cash paid for interest			0.3	0.9	0.6